Kevin Doody serves as Executive at INVO Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Doody has executed 3 insider transactions totaling $168.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 1, 2022 involved purchasing 177,306 shares valued at $168.4K.
Kevin Doody currently holds 177,306 shares of INVO Bioscience, Inc. (INVO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Doody has been a net buyer of INVO stock. They have purchased $168.4K and sold $0 worth of shares.
Kevin Doody's most recent insider trade was on Jun 1, 2022, when they purchased 177,306 shares at $0.95 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 31, 2020 | INVO | $0 | Award | 8,184 | $N/A | Discretionary |